FSCC - ETF AI Analysis
Top Page
Federated Hermes MDT Small Cap Core ETF (FSCC)
Rating:65Neutral
Price Target:―
Positive Factors
Broad Sector Diversification
The ETF spreads its investments across many sectors, including industrials, health care, financials, and technology, which helps reduce the impact if any one area of the market struggles.
Supportive Recent Performance
The fund has shown steady gains over the past month, three months, and year-to-date, suggesting its strategy has been working in the current market.
Growing Small-Cap Portfolio
With over $100 million in assets and a mix of small-cap companies that include several strong recent performers among the top holdings, the ETF offers targeted exposure to a segment that can provide growth potential.
Negative Factors
High U.S. Concentration
Almost all of the ETF’s assets are invested in U.S. companies, offering very limited geographic diversification outside the United States.
Moderate Expense Ratio
The fund’s expense ratio is not especially low for an ETF, which means fees may take a noticeable bite out of long-term returns compared with cheaper index alternatives.
Small-Cap Volatility Risk
Because the ETF focuses on small-cap stocks, investors should be prepared for potentially larger price swings and higher risk during market downturns.
FSCC vs. SPDR S&P 500 ETF (SPY)
AUM164.56M
RegionNorth America
Expense Ratio0.36%
Beta1.14
IssuerFederated Hermes
Inception DateJul 31, 2024
Dividend Yield0.28%
Asset ClassEquity
Index TrackedNo Underlying Index
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume47,314
30 Day Avg. Volume64,325
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
37.78Price Target Upside― Downside
Rating ConsensusModerate Buy
Number of Analyst Covering310
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
FSCC Summary
Federated Hermes MDT Small Cap Core ETF (FSCC) is an actively managed fund that focuses on small U.S. companies across many industries, rather than tracking a specific index. It holds a wide mix of stocks in areas like industrials, health care, financials, and technology. Examples of companies in the fund include BankUnited and American Healthcare REIT. An investor might consider FSCC to seek long-term growth and add diversification beyond large, well-known stocks. However, small-cap stocks can be more volatile, so the value of this ETF can go up and down more sharply than the overall market.
How much will it cost me?The Federated Hermes MDT Small Cap Core ETF (FSCC) has an expense ratio of 0.36%, which means you’ll pay $3.60 per year for every $1,000 invested. This expense ratio is slightly higher than average because the fund is actively managed, requiring more research and expertise to select small-cap stocks with growth potential.
What would affect this ETF?The FSCC ETF, focused on U.S. small-cap companies across diverse sectors like Industrials, Financials, and Health Care, could benefit from economic growth and innovation in these industries, as smaller firms often thrive in expanding markets. However, it may face challenges from rising interest rates, which can increase borrowing costs for small businesses, and economic slowdowns, which tend to impact smaller companies more significantly. Regulatory changes or sector-specific disruptions could also influence the ETF's performance.
FSCC Top 10 Holdings
FSCC is a U.S.-focused small-cap fund with a clear tilt toward industrials, health care, and financials, and a few standout names doing the heavy lifting. Powell Industries and Bloom Energy have been rising sharply, acting like twin engines for recent performance. Mirum Pharmaceuticals and BrightSpring Health are also contributing, though their high leverage means the ride could be bumpy. On the flip side, SPS Commerce has been losing steam, and Brookfield Infrastructure has been dragging the fund, reminding investors that this small-cap mix comes with both sparks and stumbles.
Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| American Healthcare REIT, Inc. | 2.53% | $4.08M | $8.92B | 55.54% | 64 Neutral | |
| Primoris Services | 1.70% | $2.73M | $7.27B | 149.96% | 75 Outperform | |
| Mirum Pharmaceuticals | 1.33% | $2.15M | $5.30B | 92.30% | 56 Neutral | |
| Powell Industries | 1.30% | $2.10M | $6.10B | 215.88% | 76 Outperform | |
| Jackson Financial Incorporation | 1.26% | $2.03M | $7.28B | 21.98% | 73 Outperform | |
| BankUnited | 1.24% | $1.99M | $3.25B | 28.34% | 74 Outperform | |
| BrightSpring Health Services, Inc. | 1.18% | $1.90M | $8.04B | 134.00% | 67 Neutral | |
| SPS Commerce | 1.16% | $1.87M | $2.06B | -58.95% | 77 Outperform | |
| Bloom Energy | 1.08% | $1.75M | $33.53B | 577.72% | 62 Neutral | |
| Talos Energy | 1.07% | $1.72M | $2.75B | 67.90% | 63 Neutral |
FSCC Technical Analysis
Negative
―
Price Trends
31.02
Negative
30.57
Negative
29.32
Negative
Market Momentum
-0.44
Positive
38.22
Neutral
50.61
Neutral
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For FSCC, the sentiment is Negative. The current price of undefined is equal to the 20-day moving average (MA) of 30.04, equal to the 50-day MA of 31.02, and equal to the 200-day MA of 29.32, indicating a bearish trend. The MACD of -0.44 indicates Positive momentum. The RSI at 38.22 is Neutral, neither overbought nor oversold. The STOCH value of 50.61 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for FSCC.
FSCC Peer Comparison
Comparison Results
Performance Comparison
FSCC
Federated Hermes MDT Small Cap Core ETF
28.68
5.15
21.89%
OSCV
Opus Small Cap Value ETF
―
―
―
SEIS
SEI Select Small Cap ETF
―
―
―
SCDV
Bahl & Gaynor Small Cap Dividend ETF
―
―
―
SIXS
ETC 6 Meridian Small Cap Equity ETF
―
―
―
FSML
Franklin Small Cap Enhanced ETF
―
―
―
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
DisclaimerThis AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents